American Portfolios Advisors’s Cytosorbents Corp CTSO Stock Holding History

American Portfolios Advisors’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1.36K	Hold	1,000	–	–	﹤0.01%	3215
2022 Q2	$2.19K	Hold	1,000	–	–	﹤0.01%	3114
2022 Q1	$3.19K	Hold	1,000	–	–	﹤0.01%	3090
2021 Q4	$4.19K	Hold	1,000	–	–	﹤0.01%	2956
2021 Q3	$8.12K	Hold	1,000	–	–	﹤0.01%	2662
2021 Q2	$7.55K	Hold	1,000	–	–	﹤0.01%	2643
2021 Q1	$8.68K	Sell	1,000 -400	-29%	-$3.81K	﹤0.01%	2446
2020 Q4	$11.2K	Hold	1,400	–	–	﹤0.01%	2063
2020 Q3	$11.2K	Hold	1,400	–	–	﹤0.01%	1943
2020 Q2	$13.9K	Hold	1,400	–	–	﹤0.01%	1798
2020 Q1	$10.8K	Hold	1,400	–	–	﹤0.01%	1774
2019 Q4	$5.39K	Hold	1,400	–	–	﹤0.01%	2248
2019 Q3	$7.04K	Hold	1,400	–	–	﹤0.01%	2062
2019 Q2	$9.25K	Hold	1,400	–	–	﹤0.01%	1928
2019 Q1	$10.6K	Hold	1,400	–	–	﹤0.01%	1808
2018 Q4	$11.3K	Hold	1,400	–	–	﹤0.01%	1574
2018 Q3	$18.1K	Hold	1,400	–	–	﹤0.01%	1519
2018 Q2	$16K	Buy	+1,400	New	+$13.3K	﹤0.01%	1539

Other funds holding CTSO

Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return

Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

American Portfolios Advisors's CTSO Position: Q3 2022 in Review

American Portfolios Advisors held its Cytosorbents Corp (CTSO) position steady in Q3 2022 at 1,000 shares worth $1.36K. The position accounts for ﹤0.01% of the portfolio, ranked #3215.

American Portfolios Advisors first reported a position in CTSO in Q2 2018 and has held it in 18 quarters since. The position peaked at $18.1K in Q3 2018. 60 funds tracked by Wall St. Rank hold CTSO as of Q3 2022.

American Portfolios Advisors held 1,000 shares of Cytosorbents Corp worth $1.36K as of Q3 2022.
American Portfolios Advisors left its Cytosorbents Corp share count unchanged in Q3 2022.
Cytosorbents Corp made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3215 holding.
American Portfolios Advisors first reported a position in Cytosorbents Corp in Q2 2018 and has held it in 18 quarters since.
American Portfolios Advisors's Cytosorbents Corp position peaked at $18.1K in Q3 2018.
60 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.